ICLR241115P350000
- 47.00
- 0.000.00%
Icon PLC Newsroom
Earnings Preview: Icon PLC to Report Financial Results Post-market on October 23
$Icon PLC(ICLR.US)$ is scheduled to release its financial results post-market on October 23 ET. Earnings PreviewAnalysts estimate $Icon PLC(ICLR.US)$ to post revenue of USD2.13B for 2024Q3, up 3.79%
Deutsche Bank Adjusts ICON Price Target to $360 From $370, Maintains Buy Rating
Barclays Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $330
Icon Price Target Cut to $330.00/Share From $350.00 by Barclays
J.P. Morgan Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $375
Barclays Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $330
Icon Initiated at Neutral by Redburn Atlantic
Redburn Atlantic Initiates Coverage On Icon With Neutral Rating, Announces Price Target of $311
Icon Is Maintained at Buy by Truist Securities
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $363
Express News | ICON PLC : Truist Securities Cuts Target Price to $363 From $383
Declining Stock and Decent Financials: Is The Market Wrong About ICON Public Limited Company (NASDAQ:ICLR)?
Jefferies Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $380
Icon Is Maintained at Outperform by Evercore ISI Group
Icon Price Target Cut to $350.00/Share From $360.00 by Evercore ISI Group
Evercore Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $350
Should You Be Adding ICON (NASDAQ:ICLR) To Your Watchlist Today?
Icon PLC | 6-K: Report of foreign private issuer (related to financial reporting)
ICON Plc Schedules Third Quarter 2024 Earnings Conference Call
Medpace, Fortrea Cut as Jefferies Reviews CROs Amid Biotech Headwinds